Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation

Zongren Zhao; Jiawei Shen; Long Zhang; Lansheng Wang; Haoyue Xu; Yuhan Han; Jun Jia; Yang Lu; Rutong Yu; Hongmei Liu

doi:10.1039/D1BM90016A

Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation

Zongren Zhao,^ab Jiawei Shen,^ac Long Zhang,^a Lansheng Wang,^a Haoyue Xu,^a Yuhan Han,^a Jun Jia,^a Yang Lu,^a Rutong Yu*^ab and Hongmei Liu*^ab

Author affiliations

* Corresponding authors

^a Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, P. R. China
E-mail: liuhongmei816@sina.com, yu.rutong@163.com
Tel: +86 17716228111

^b Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P. R. China

^c Department of Neurosurgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P. R. China

Abstract

Correction for ‘Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation’ by Zongren Zhao et al., Biomater. Sci., 2020, 8, 5306–5316, DOI: 10.1039/D0BM00338G.

Biomaterials Science

Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation

Social activity

Search articles by author

Spotlight

Advertisements